Changes in IDH2, TET2 and KDM2B Gene Expression After Treatment With Classic Chemotherapeutic Agents and Decitabine in Myelogenous Leukemia Cell Lines

BACKGROUND: Hematological malignancies are a heterogeneous group of tumors with increased proliferative and auto-replicative capacity. Despite treatment advances, post-treatment quality of life remains highly affected. Studies addressing the molecular mechanisms of these diseases are critical for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Jayse, Dexheimer, Georgia Muccillo, Reckzigel, Laura, Goettert, Marcia, Biolchi, Vanderlei, Abujamra, Ana Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153660/
https://www.ncbi.nlm.nih.gov/pubmed/32300452
http://dx.doi.org/10.14740/jh531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153660/
https://www.ncbi.nlm.nih.gov/pubmed/32300452
http://dx.doi.org/10.14740/jh531

Ejemplares similares